Tuberculous meningitis in Denmark: a review of 50 cases

被引:70
|
作者
Christensen, Anne-Sophie H. [1 ]
Andersen, Ase B. [1 ]
Thomsen, Vibeke O. [2 ]
Andersen, Peter H. [3 ]
Johansen, Isik S. [4 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[2] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark
[3] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark
[4] Hvidovre Univ Hosp, Dept Infect Dis, Copenhagen, Denmark
关键词
DIAGNOSIS; COUNTRY; RISK;
D O I
10.1186/1471-2334-11-47
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Tuberculous meningitis is the most severe manifestation of extrapulmonary tuberculosis with a high mortality rate and a high rate of sequelae among survivors. The aim of this study is to assess the current epidemiology, clinical features, diagnostic procedures, treatment and outcome in patients with tuberculous meningitis in Denmark, a country with a low tuberculosis incidence. Methods: A nationwide retrospective study was conducted, comprising all patients notified with tuberculous meningitis (TBM) in Denmark from 2000-2008. Medical records were reviewed using a standardised protocol. Results: Fifty patients, including 12 paediatric patients, were identified. 78% of the patients were immigrants from countries of high tuberculosis endemicity. 64% of all patients had a pre-existing immunosuppressive condition; 10% were HIV positive, 48% were HIV seronegative and 42% had an unknown HIV status. Median symptom duration before admission was 14 days in the Danish patient population and 20 days in the immigrant group. Biochemical analysis of cerebrospinal fluid (CSF) samples revealed pleocytosis in 90% with lymphocyte predominance in 66%. Protein levels were elevated in 86%. The most common findings on neuro-radiological imaging were basal meningeal enhancement, tuberculomas and hydrocephalus. Lumbar puncture was performed on 42 patients; 31 of these specimens (74%) had a positive CSF culture for mycobacteria and 9.5% were smear positive for acid-fast bacilli. The overall mortality rate was 19% and 48% of the remaining patients had neurological sequelae of varying degree. Conclusion: TBM is a rare but severe manifestation of extrapulmonary TB in Denmark. The clinician must be prepared to treat empirically if the suspicion of TBM has arisen to improve treatment outcome.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Racemose neurocysticercosis simulating tuberculous meningitis
    Pandey, Prakash C.
    Kalita, Jayantee
    Sardhara, Jayesh
    Jain, Neeraj
    Prasad, Pallavi
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (11) : 1361 - 1364
  • [32] Tuberculous meningitis: Challenges in diagnosis and management
    Mechai, F.
    Bouchaud, O.
    REVUE NEUROLOGIQUE, 2019, 175 (7-8) : 451 - 457
  • [33] Diagnosis of tuberculous meningitis: challenges and promises
    Philip, Noraini
    William, Timothy
    John, Daisy Vanitha
    MALAYSIAN JOURNAL OF PATHOLOGY, 2015, 37 (01) : 1 - 9
  • [34] Tuberculous meningitis: where to from here?
    Donovan, Joseph
    Thwaites, Guy E.
    Huynh, Julie
    CURRENT OPINION IN INFECTIOUS DISEASES, 2020, 33 (03) : 259 - 266
  • [35] Tuberculous and brucellosis meningitis differential diagnosis
    Erdem, Hakan
    Senbayrak, Seniha
    Gencer, Serap
    Hasbun, Rodrigo
    Karahocagil, Mustafa Kasim
    Sengoz, Gonul
    Karsen, Hasan
    Kaya, Selcuk
    Civljak, Rok
    Inal, Ayse Seza
    Pekok, Abdullah Umut
    Celen, Mustafa Kemal
    Deniz, Secil
    Ulug, Mehmet
    Demirdal, Tuna
    Namiduru, Mustafa
    Tekin, Recep
    Guven, Tumer
    Parlak, Emine
    Bolukcu, Sibel
    Avci, Meltem
    Sipahi, Oguz Rept
    Nayman-Alpat, Saygin
    Yasar, Kadriye
    Pehlivanoglu, Filiz
    Yilmaz, Emel
    Ates-Guler, Selma
    Mutlu-Yilmaz, Esmeray
    Tosun, Selma
    Sirmatel, Fatma
    Sahin-Horasan, Elif
    Akbulut, Ayhan
    Johansen, Isik Sorpuncu
    Simeon, Soline
    Batirel, Ayse
    Oztoprak, Nefise
    Cag, Yasemin
    Catroux, Melanie
    Hansmann, Yves
    Kadanali, Ayten
    Turgut, Huseyin
    Baran, Ali Irfan
    Gul, Hanefi Cem
    Karaahmetoglu, Gokhan
    Sunnetcioglu, Mahmut
    Haykir-Solay, Asli
    Denk, Affan
    Ayaz, Celal
    Kose, Sukran
    Gorenek, Levent
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2015, 13 (02) : 185 - 191
  • [36] Deciphering Genetic Susceptibility to Tuberculous Meningitis
    Schurz, Haiko
    Glanzmann, Brigitte
    Bowker, Nicholas
    van Toorn, Ronald
    Solomons, Regan
    Schoeman, Johan
    van Helden, Paul D.
    Kinnear, Craig J.
    Hoal, Eileen G.
    Moeller, Marlo
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [37] Advances in the diagnosis and treatment of tuberculous meningitis
    Thwaites, Guy E.
    CURRENT OPINION IN NEUROLOGY, 2013, 26 (03) : 295 - 300
  • [38] INCIDENCE OF HYDROCEPHALUS IN TUBERCULOUS MENINGITIS PATIENTS
    Riaz, Muhammad
    Zeb, Alam
    Babar, Zara
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 261 - 264
  • [39] Tuberculous meningitis: advances in diagnosis and treatment
    Toeroek, M. E.
    BRITISH MEDICAL BULLETIN, 2015, 113 (01) : 117 - 131
  • [40] Epidemiology of tuberculous lymphadenitis in Denmark: A nationwide register-based study
    Mathiasen, Victor Dahl
    Eiset, Andreas Halgreen
    Andersen, Peter Henrik
    Wejse, Christian
    Lillebaek, Troels
    PLOS ONE, 2019, 14 (08):